• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 42 -6 (80) 2025 - Abdullayeva U.K., Sharipov M.Sh. - THE POSSIBILITY OF USING HYDROGEN WATER IN CORRECTING MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

42 -6 (80) 2025 - Abdullayeva U.K., Sharipov M.Sh. - THE POSSIBILITY OF USING HYDROGEN WATER IN CORRECTING MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

THE POSSIBILITY OF USING HYDROGEN WATER IN CORRECTING MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Abdullayeva U.K. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Sharipov M.Sh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Inflammatory bowel diseases are chronic relapsing immunologically mediated gastrointestinal diseases of unknown etiology. Recently, more and more studies have been devoted to the relationship between human microbiota and gastrointestinal tract function. Due to the rapid development, high therapeutic efficacy, and biosafety of gas-based theranostics, hydrogen medicine has gained particular importance, since hydrogen gas obtained from microorganisms has powerful antioxidant, antiapoptotic, and anti-inflammatory effects in many disease models

Key words: inflammatory bowel disease, gut microbiota, treatment, hydrogen water

First page

218

Last page

221

For citation:Abdullayeva U.K., Sharipov M.Sh. - THE POSSIBILITY OF USING HYDROGEN WATER IN CORRECTING MICROBIOTA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE//New Day in Medicine 6(80)2025 218-221 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Кузнецова Г.Г. О стадиях нарушения биоценоза кишечника при хронических колитах. Сов. Мед. 1972;11:67
  2. Максимов В.И., Родоман В.Е. Кислотность кишечника как защитный фактор организма хозяина. Микробиология. 1998;4:96
  3. Медведев О.С. Роль водорода и метана микробиома человека и животных в обеспечении антиоксидантной защиты организма. Успехи современной биологии. 2022; 142 (4): 349–364. DOI:10.31857/S004213242204007X.
  4. Парфенов А.И. Энтерология. Руководство для врачей. М., Медицинское информatsiонное агентство (МИА); 2009:880
  5. Bernstein C.N., Robert M.E., Eysselein V.E. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn’s disease. American Journal of Gastroenterology. 1993;88(6).
  6. Carbonero F, Benefiel AC, Gaskins HR. Contributions of the microbial hydrogen economy to colonic homeostasis. Nat Rev Gastroenterol Hepatol PMID:22585131. 2012;9:504–518. doi:10.1038/nrgastro.2012.85.
  7. Chen L, Zhou SF, Su L, Song J. Gas-mediated cancer bioimaging and therapy. ACS Nano. PMID:31538764. 2019;13:10887–10917. doi:10.1021/acsnano.9b04954.
  8. Cummings J.H., Macfarlane G.T., Macfarlane S. Intestinal bacteria and ulcerative colitis. Current issues in intestinal microbiology. 2003;4(1):9–20.
  9. He J, Xiong S, Zhang J, Wang J, Sun A, Mei X, Sun X, Zhang C, Wang Q. Protective effects of hydrogen-rich saline on ulcerative colitis rat model. J Surg Res PMID:23773716. 2013;185:174–181. doi:10.1016/j. jss.2013.05.047.
  10. Ichikawa Y., Hirano S., Sato B. et al. Guidelines for the selection of hydrogen gas inhalers based on hydrogen explosion accidents. Med. Gas Res. 2023; 13 (2): 43–48. DOI: 10.4103/2045-9912.344972.

    file

    download